UNC13C
Basic information
Region (hg38): 15:53978201-54628707
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UNC13C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 100 | 101 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 101 | 3 | 0 |
Variants in UNC13C
This is a list of pathogenic ClinVar variants found in the UNC13C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-54012908-T-C | not specified | Uncertain significance (Sep 06, 2022) | ||
15-54012916-T-G | not specified | Uncertain significance (May 20, 2024) | ||
15-54013117-A-T | not specified | Uncertain significance (Mar 01, 2023) | ||
15-54013174-A-G | not specified | Uncertain significance (Dec 16, 2023) | ||
15-54013186-C-T | Clubfoot;Abnormality of the face;Cystic renal dysplasia;Renal cyst;Abnormal finger morphology | Uncertain significance (Jan 01, 2019) | ||
15-54013187-G-A | not specified | Uncertain significance (Jun 07, 2024) | ||
15-54013190-T-A | not specified | Uncertain significance (Apr 25, 2022) | ||
15-54013210-C-A | not specified | Uncertain significance (May 02, 2024) | ||
15-54013243-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
15-54013270-A-T | not specified | Uncertain significance (Jan 19, 2022) | ||
15-54013379-G-A | not specified | Uncertain significance (Apr 08, 2024) | ||
15-54013380-C-G | not specified | Uncertain significance (Jun 16, 2023) | ||
15-54013424-A-C | not specified | Uncertain significance (Dec 13, 2023) | ||
15-54013507-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
15-54013534-A-G | not specified | Uncertain significance (Aug 16, 2022) | ||
15-54013547-A-G | not specified | Uncertain significance (Feb 13, 2024) | ||
15-54013559-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
15-54013595-G-A | not specified | Uncertain significance (Aug 02, 2023) | ||
15-54013596-T-A | not specified | Uncertain significance (Nov 29, 2023) | ||
15-54013638-G-T | not specified | Uncertain significance (Dec 13, 2021) | ||
15-54013681-C-G | not specified | Uncertain significance (Jan 02, 2024) | ||
15-54013688-A-G | not specified | Uncertain significance (Apr 29, 2024) | ||
15-54013702-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
15-54013706-A-G | not specified | Uncertain significance (May 24, 2024) | ||
15-54013726-G-A | not specified | Uncertain significance (Oct 10, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UNC13C | protein_coding | protein_coding | ENST00000260323 | 32 | 615706 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.17e-15 | 1.00 | 124574 | 0 | 143 | 124717 | 0.000573 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.143 | 1105 | 1.09e+3 | 1.01 | 0.0000539 | 14553 |
Missense in Polyphen | 384 | 409.8 | 0.93703 | 5508 | ||
Synonymous | -1.50 | 429 | 391 | 1.10 | 0.0000197 | 4019 |
Loss of Function | 5.53 | 44 | 105 | 0.418 | 0.00000580 | 1348 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000539 | 0.000534 |
Ashkenazi Jewish | 0.000399 | 0.000398 |
East Asian | 0.00147 | 0.00144 |
Finnish | 0.000934 | 0.000929 |
European (Non-Finnish) | 0.000569 | 0.000557 |
Middle Eastern | 0.00147 | 0.00144 |
South Asian | 0.000395 | 0.000392 |
Other | 0.000848 | 0.000826 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in vesicle maturation during exocytosis as a target of the diacylglycerol second messenger pathway. May be involved in the regulation of synaptic transmission at parallel fiber - Purkinje cell synapses (By similarity). {ECO:0000250}.;
- Pathway
- Synaptic vesicle cycle - Homo sapiens (human);Synaptic Vesicle Pathway
(Consensus)
Recessive Scores
- pRec
- 0.0999
Intolerance Scores
- loftool
- 0.328
- rvis_EVS
- -1.67
- rvis_percentile_EVS
- 2.7
Haploinsufficiency Scores
- pHI
- 0.110
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.588
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.154
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | High |
Mouse Genome Informatics
- Gene name
- Unc13c
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- chemical synaptic transmission;neuromuscular junction development;synaptic vesicle docking;synaptic vesicle priming;synaptic vesicle maturation;negative regulation of synaptic plasticity;synaptic transmission, glutamatergic;intracellular signal transduction;dense core granule priming;presynaptic dense core vesicle exocytosis
- Cellular component
- plasma membrane;cell junction;synaptic vesicle membrane;neuromuscular junction;presynaptic membrane;terminal bouton;calyx of Held;presynaptic active zone;parallel fiber to Purkinje cell synapse;presynaptic active zone cytoplasmic component
- Molecular function
- calcium ion binding;calmodulin binding;phospholipid binding;syntaxin-1 binding;diacylglycerol binding